Shareholder Action Targets $580M GE-Clarient Deal

Law360, New York (October 28, 2010, 7:49 PM EDT) -- A shareholder of Clarient Inc. has launched a proposed class action seeking to block a planned $580 million buyout of the cancer diagnostic company by General Electric Co.’s health care unit, claiming the offer is “grossly inadequate” and deprives shareholders of their investment.

Bette R. Grayson Kurzweil filed the complaint in the Delaware Chancery Court on Wednesday in response to GE Healthcare’s announcement on Oct. 22 that it would pay $5 per common share and $20 per preferred share to acquire Clarient in a move to...
To view the full article, register now.